UK markets closed

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3500+0.0200 (+1.50%)
At close: 04:00PM EDT
1.3800 +0.03 (+2.22%)
After hours: 07:25PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
36,464
0
0
Cost of revenue
-936
-936
17,908
16,347
23,608
Gross profit
936
936
18,556
-16,347
-23,608
Operating expenses
Research development
24,962
24,962
23,559
-
-
Selling general and administrative
19,543
19,543
15,933
21,222
15,909
Total operating expenses
44,505
44,505
39,492
21,222
15,909
Operating income or loss
-43,569
-43,569
-20,936
-37,569
-39,517
Interest expense
3,320
3,361
4,001
6,383
3,496
Total other income/expenses net
10,141
10,141
39,198
-122,542
1,518
Income before tax
-36,093
-36,093
14,241
-166,450
-41,118
Income tax expense
-1,897
-1,897
1,516
-2,822
-6,274
Income from continuing operations
-34,196
-34,196
12,725
-163,628
-34,844
Net income
-34,196
-34,196
12,725
-163,628
-34,844
Net income available to common shareholders
-34,196
-34,196
12,725
-163,628
-34,844
Basic EPS
-
-0.30
0.10
-2.40
-1.95
Diluted EPS
-
-0.30
-0.25
-2.40
-1.95
Basic average shares
-
120,639
105,564
67,791
17,885
Diluted average shares
-
120,639
111,055
67,791
17,885